Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia

Shunt occlusion prior to lenvatinib administration prevented hyperammonemia and hepatic encephalopathy. Shunt occlusion may be an effective treatment option to administer molecular target agents in patients with portosystemic shunts.